Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor

Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor — Trials · CancerIndex

Clinical trials

Registered studies

13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 4
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Mayo Clinic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05494580	Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer	completed	Phase 1 / Phase 2	29	Sun Yat-sen UniversityOTHER	1	Mar 10, 2026	clinicaltrials

Data updated 22 days agoSource updated Mar 10, 2026source: clinicaltrials